Daiichi Sankyo Co.
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Daiichi Sankyo Company Limited (第一三共株式会社 Daiichi Sankyō Kabushiki-gaisha?) (Template:Tyo) is a joint holding company established in 2005 by Sankyo Co., Ltd. (三共株式会社 Sankyō Kabushiki-gaisha?) and Daiichi Pharmaceutical Co., Ltd. (第一製薬株式会社 Daiichi Seiyaku Kabushiki-gaisha?), which are pharmaceutical companies based in Japan. Its main offices are located in Chūō-ku, Tokyo.
Major products of Daiichi Sankyo Group
Sankyo
- Benicar(olmesartan medoxomil)
- Mevalotin (pravastatin)
- Loxonin (loxoprofen)
- Olmetec (olmesartan)
- Captopril
- Zantac (ranitidine)
- WelChol (colesevelam HCl)
Daiichi Pharmaceutical
- Cravit (levofloxacin)
- Evoxac (cevimeline)
- FloxinOtic (ofloxacin)
External links
Template:TOPIX 100 Template:Japan-company-stub Template:Med-company-stub
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
